Sundrug CoSDGCF 82 WACC % is 2.67% as of Jun. 27, 2026, which is 42% above its 10-year median of 1.88. GuruFocus rates SDGCF with a GF Score™ of 82/100 and a GF Value™ of $34.93. The stock has 1 warning sign investors should review. Among 695 Healthcare Providers & Services companies, Sundrug Co ranks better than 89.93% on this metric.
As of today (2026-06-27), Sundrug Co's weighted average cost of capital is 2.67%%. Sundrug Co's ROIC % is 10.64% (calculated using TTM income statement data).
Sundrug Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
For a comprehensive WACC calculation, please access the WACC Calculator.
Sundrug Co (OTCPK:SDGCF) WACC % Explanation
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Sundrug Co's weighted average cost of capital is 2.67%%. Sundrug Co's ROIC % is 10.64% (calculated using TTM income statement data).
Sundrug Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Be Aware
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
Related Terms
Sundrug Co WACC % Historical Data
* Premium members only.
The historical data trend for Sundrug Co's WACC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sundrug Co's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co WACC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's WACC % distribution charts can be found below:
* The bar in red indicates where Sundrug Co's WACC % falls into.
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC
=
E
/
(E + D)
*
Cost of Equity
+
D
/
(E + D)
*
Cost of Debt
*
(1 - Tax Rate)
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Sundrug Co's market capitalization (E) is $2752.888 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2026, Sundrug Co's latest one-year quarterly average Book Value of Debt (D) is $295.6574 Mil.
a) weight of equity = E / (E + D) = 2752.888 / (2752.888 + 295.6574) = 0.903
b) weight of debt = D / (E + D) = 295.6574 / (2752.888 + 295.6574) = 0.097
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 2.65%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Sundrug Co's beta is 0.0415.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 2.65% + 0.0415 * 6% = 2.899%
3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2026, Sundrug Co's interest expense (positive number) was $2.521 Mil. Its total Book Value of Debt (D) is $295.6574 Mil.
Cost of Debt = 2.521 / 295.6574 = 0.8527%.
4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = 95.381 / 302.511 = 31.53%.
Sundrug Co's Weighted Average Cost Of Capital (WACC) for Today is calculated as:
WACC
=
E / (E + D)
*
Cost of Equity
+
D / (E + D)
*
Cost of Debt
*
(1 - Tax Rate)
=
0.903
*
2.899%
+
0.097
*
0.8527%
*
(1 - 31.53%)
=
2.67%
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co (SDGCF) has a WACC % of 2.67% as of Jun. 27, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Sundrug Co and its competitors. This is 42% above median its historical median of 1.88. Over the past decade, Sundrug Co's WACC % has ranged from 1.27 to 3.89. According to the industry distribution chart, Sundrug Co ranks #70 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 10.1%.
Is Sundrug Co's WACC % too high?
Sundrug Co's current WACC % of 2.67% is 42% above median its 10-year median of 1.88. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 3.89. The Healthcare Providers & Services industry median WACC % is 8.57. Sundrug Co's value of 2.67% is 68.8% below this industry median. Based on the distribution chart, Sundrug Co ranks #70 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sundrug Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's WACC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #70 out of 695 companies for WACC %. This places Sundrug Co in the top 10% of its industry — outperforming the majority of peers. The industry median WACC % is 8.57. Sundrug Co's value of 2.67% is 68.8% below this benchmark. Historically, Sundrug Co's own WACC % has ranged from 1.27 to 3.89 over the past decade. While the company's 10-year median is 1.88 vs. the industry median of 8.57, Sundrug Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Healthcare Providers & Services company?
The median WACC % among Healthcare Providers & Services companies is 8.57, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current WACC % of 2.67% is 68.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median WACC % is 8.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current WACC % is 2.67%, which is 42% above median its own 10-year median of 1.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current WACC % of 2.67%. The stock's GF Value™ is $34.93, compared to a current price of $28.18 — trading 19.3% below its estimated fair value. The current WACC % is 2.67%, which is 42% above median its 10-year median of 1.88 and 68.8% below the Healthcare Providers & Services industry median of 8.57. Sundrug Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current WACC % is 2.67% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 19.3% below its estimated GF Value™ of $34.93.
Key valuation signals for SDGCF:
WACC %: 2.67% (42% above median its 10-year median of 1.88)
GF Value™: $34.93 vs. price of $28.18 (19.3% below fair value)
Industry Position: 68.8% below the Healthcare Providers & Services median (#70 of 695)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
82GF Score
Get the complete analysis for SDGCF
WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 
